A detailed history of Ubs Group Ag transactions in Dermata Therapeutics Inc Wt Ex stock. As of the latest transaction made, Ubs Group Ag holds 5,042 shares of DRMAW stock, worth $50. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,042
Previous 1,485 239.53%
Holding current value
$50
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$0.01 - $0.02 $35 - $71
3,557 Added 239.53%
5,042 $0
Q1 2024

May 13, 2024

SELL
$0.01 - $0.02 $18 - $37
-1,868 Reduced 55.71%
1,485 $0
Q4 2023

Feb 09, 2024

SELL
$0.01 - $0.02 $22 - $45
-2,257 Reduced 40.23%
3,353 $0
Q3 2023

Nov 09, 2023

BUY
$0.01 - $0.03 $56 - $168
5,610 New
5,610 $0
Q1 2023

May 12, 2023

SELL
$0.02 - $0.06 $102 - $306
-5,105 Reduced 73.93%
1,800 $0
Q4 2022

Feb 08, 2023

SELL
$0.0 - $0.08 $0 - $175
-2,195 Reduced 24.12%
6,905 $0
Q3 2022

Nov 10, 2022

BUY
$0.06 - $0.16 $546 - $1,456
9,100 New
9,100 $1,000
Q2 2022

Aug 10, 2022

SELL
$0.06 - $0.19 $196 - $620
-3,267 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$0.14 - $0.5 $517 - $1,846
-3,693 Reduced 53.06%
3,267 $1,000
Q4 2021

Feb 14, 2022

BUY
$0.36 - $1.4 $1,425 - $5,544
3,960 Added 132.0%
6,960 $3,000
Q3 2021

Nov 15, 2021

BUY
$0.81 - $1.3 $2,430 - $3,900
3,000 New
3,000 $2,000

Others Institutions Holding DRMAW

About DERMATA THERAPEUTICS INC WT EX


  • Ticker DRMAW
  • Sector Healthcare
  • Industry Biotechnology
More about DRMAW
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.